INmune BioINMB
那斯達克 · USD
1.59
-0.01
(-0.63%)
盤中 01/22 01:35 (UTC+8)
01/22 01:35 (UTC+8)
INmune BioINMB
1.59
-0.01
(-0.63%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- -
- -
- -
- 0.00
- -
- -
- 21.05
- -6.52
- -34.88
- -50.00
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | 50 | - | - | - | 14 | 28 | 43 | 46 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | 50 | - | - | - | 14 | 28 | 43 | 46 |
營業費用 | 7,433 | 24,571 | 9,955 | 9,467 | 12,286 | - | 11,031 | 8,407 | 8,571 | 6,457 |
研發費用 | 4,887 | 5,804 | 7,639 | 7,353 | 10,067 | 7,053 | 8,693 | 6,007 | 5,985 | 4,148 |
推銷及管理費用 | 2,546 | 2,253 | 2,316 | 2,114 | 2,219 | 2,812 | 2,338 | 2,400 | 2,586 | 2,309 |
非經常性項目費用 | - | 16,514 | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -7,433 | -24,571 | -9,905 | -9,467 | -12,286 | -9,865 | -11,017 | -8,379 | -8,528 | -6,411 |
其他收入及費用 | 961 | 113 | 166 | 249 | 193 | 119 | -8 | -29 | -35 | -90 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -6,472 | -24,458 | -9,739 | -9,218 | -12,093 | -9,746 | -11,025 | -8,408 | -8,563 | -6,501 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -6,472 | -24,458 | -9,739 | -9,218 | -12,093 | -9,746 | -11,025 | -8,408 | -8,563 | -6,501 |
基本每股稅後盈餘(元) | -0.24 | -1.05 | -0.43 | -0.40 | -0.60 | -0.50 | -0.61 | - | -0.48 | -0.36 |
稀釋每股稅後盈餘(元) | -0.19 | -1.06 | -0.43 | -0.40 | -0.60 | -0.50 | -0.61 | -0.47 | -0.47 | -0.37 |
基本平均股數(千股) | 26585.00 | 23298.00 | 22496.00 | 22259.00 | 20185.00 | 19307.00 | 18026.00 | - | 18008.00 | 17945.00 |
稀釋平均股數(千股) | 26585.00 | 23298.00 | 22496.00 | 22259.00 | 20185.00 | 19307.00 | 18026.00 | - | 18008.00 | 17945.00 |
還原基本每股稅後盈餘(元) | -0.24 | -1.05 | -0.43 | -0.40 | -0.60 | -0.50 | -0.61 | - | -0.48 | -0.36 |
還原稀釋每股稅後盈餘(元) | -0.19 | -1.06 | -0.43 | -0.40 | -0.60 | -0.50 | -0.61 | -0.47 | -0.47 | -0.37 |
還原基本平均股數(千股) | 26,585 | 23,298 | 22,496 | 22,259 | 20,185 | 19,307 | 18,026 | - | 18,008 | 17,945 |
還原稀釋平均股數(千股) | 26,585 | 23,298 | 22,496 | 22,259 | 20,185 | 19,307 | 18,026 | - | 18,008 | 17,945 |
EBITDA(千元) | -6,444 | -24,458 | -9,739 | -9,212 | -12,078 | -9,722 | -10,991 | -8,363 | -8,509 | -6,443 |